Clinical Trial Update: Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin. [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating thymosin alpha-1 in combination with peg-interferon alfa-2a and ribavirin for chronic hepatitis C patients nonresponsive to I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED